LNTH

Lantheus Holdings, Inc. NGM · LNTH

$103.85 -0.76 (-0.73%)

Neutral · -0.33σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $6.8B

P/E (ttm) 24.8

Forward P/E 16.5

Beta (5y) -0.06

Shares out 65.1M

Div yield —

Profitability & returns

ROE 23.5%

Net margin 18.0%

FCF margin 27.3%

Debt / equity 0.52

Trading information

Last price $103.85

Day range $101.04 – $104.70

52-wk range $63.45 – $111.86

Avg volume 1.0M

RSI (2) 27.8

Trend zone Neutral

52-week range · today's price

$63.45$111.86

Company

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange NGM

Next earnings 2026-08-06

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pu…